In this resource library we share documents, presentations, forms, videos and useful links from Pinnacle and the wider sector.
Use the search box and filters to help find what you're looking for or view all COVID-19 resources
Can't find what you need? Try searching in programmes.
Jo Scott-Jones and Dave Maplesden discuss empagliflozin and ketoacidosis, decision to fund fosfomycin in the community, latent autoimmune diabetes and more.
Pertussis, or whooping cough, is a highly contagious respiratory disease caused by Bordetella pertussis. While it can affect people of all ages, it is particularly dangerous for infants and young children. Despite vaccination efforts, pertussis continues to cause periodic outbreaks in New Zealand due to waning immunity over time.
We have three full-time and two part-time staff in the nurse lead space across the Pinnacle network. They work as a team to support over 450 nurses (Waikato, Lakes, Taranaki, Tairāwhiti) with a key focus on growing and supporting our nursing kaimahi (staff).
Jo Scott-Jones and Dave Maplesden discuss ACC Integrated Care Pathways Musculoskeletal, Amoxicillin dosing in acute otitis media, Microplastics, nanoplastics and CVD risk, and more.
The Quality Improvement Programme (QI Programme) launched 1 July 2024. The programme will be rolled out over three years, with year one focusing on building Quality Improvement capability in general practice.
From support with new role implementation such as primary care assistants (PCAs) to mapping and redesign of current processes such as repeat prescribing processes, your local Pinnacle development manager can support your changing practice needs.
Further to feedback from last year's Pinnacle workforce survey requesting more education opportunities, we've launched a new fortnightly lunchtime learnings programme. Watch a recording of the latest one here, available for two weeks.
Dr Jo Scott-Jones and Dr Dave Maplesden discuss non-subsidised medications for beneficiaries, RNZCGP statement on medical cannabis prescribing, IFNAR1 deficiency, and more.
If you are in a pickle with an aspect of your practice population care (immunisation, cervical screening, CVRAs), Jo Scott-Jones suggests reviewing, judging and and acting on a "set piece" response.
MenB (Bexsero) vaccine is funded from 1 March 2023 and will become part of the National Immunisation Schedule with a primary course administered at the 3-month and 5-month immunisation events followed by a booster dose at the 12-month vaccination event. View relevant IMAC web link resources here.